- Home
- MRM vs EVGN Comparison
MRM vs EVGN Comparison
Compare MRM & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRM
- EVGN
- Stock Information
- Founded
- MRM 2000
- EVGN 1999
- Country
- MRM Japan
- EVGN Israel
- Employees
- MRM N/A
- EVGN N/A
- Industry
- MRM Other Consumer Services
- EVGN Agricultural Chemicals
- Sector
- MRM Consumer Discretionary
- EVGN Industrials
- Exchange
- MRM Nasdaq
- EVGN Nasdaq
- Market Cap
- MRM 10.4M
- EVGN 11.4M
- IPO Year
- MRM 2020
- EVGN N/A
- Fundamental
- Price
- MRM $2.19
- EVGN $1.25
- Analyst Decision
- MRM
- EVGN Strong Buy
- Analyst Count
- MRM 0
- EVGN 1
- Target Price
- MRM N/A
- EVGN $3.50
- AVG Volume (30 Days)
- MRM 6.6M
- EVGN 83.8K
- Earning Date
- MRM 05-20-2025
- EVGN 08-19-2025
- Dividend Yield
- MRM N/A
- EVGN N/A
- EPS Growth
- MRM 27.65
- EVGN N/A
- EPS
- MRM 0.18
- EVGN N/A
- Revenue
- MRM $52,786,758.00
- EVGN $6,765,000.00
- Revenue This Year
- MRM N/A
- EVGN N/A
- Revenue Next Year
- MRM N/A
- EVGN $113.18
- P/E Ratio
- MRM $14.33
- EVGN N/A
- Revenue Growth
- MRM 21.55
- EVGN N/A
- 52 Week Low
- MRM $0.34
- EVGN $0.95
- 52 Week High
- MRM $8.39
- EVGN $4.29
- Technical
- Relative Strength Index (RSI)
- MRM 64.42
- EVGN 48.17
- Support Level
- MRM $1.10
- EVGN $1.18
- Resistance Level
- MRM $3.53
- EVGN $1.36
- Average True Range (ATR)
- MRM 0.33
- EVGN 0.07
- MACD
- MRM 0.13
- EVGN -0.00
- Stochastic Oscillator
- MRM 44.81
- EVGN 52.17
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.